Stockholders’ Deficit |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Equity [Abstract] | |
| Stockholders’ Deficit | Note 5 – Stockholders’ Deficit
As of December 31, 2024, and 2023, the Company has authorized shares of common stock, with a par value of $ per share. The Company had shares issued and outstanding as of December 31, 2024, and 2023. Each common share is entitled to one vote.
Shares issued for services
The Company issued shares to consultants during the year ended December 31, 2023. The shares were valued at the closing stock price on the date of grant for a total value of $68,800.
Shares issued in exchange for convertible debt – related party
The Company issued shares in conversion of a related party note payable during the year ended December 31, 2023. The shares were valued at $73,616 based on the closing stock price on date of conversion. Due to the related party nature of the transaction, the gain of $31,869 was recorded in additional paid in capital for a total of $105,485.
Shares issued in offering
In November 2023, the Company entered into subscription agreements with investors to issue shares of common stock at $ per share. The Company received $500,000 in proceeds from the issuance and has placed an allowance on the remaining subscription funds receivable of $500,000.
Stock Split
On January 29, 2024, the Company executed a 4-for-1 forward stock split. As a result of the forward stock split, every one share of issued and outstanding common stock will be automatically split into four issued and outstanding shares of common stock, without any change in the par value per share. No fractional shares will be issued as a result of the Forward Stock Split. These financial statements have been retrospectively adjusted to reflect the effects of the stock split.
|